Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Nature
.
2024 Apr;628(8008):E2.
doi: 10.1038/s41586-024-07344-w.
Authors
Christopher O Barnes
1
,
Claudia A Jette
1
,
Morgan E Abernathy
1
,
Kim-Marie A Dam
1
,
Shannon R Esswein
1
,
Harry B Gristick
1
,
Andrey G Malyutin
2
,
Naima G Sharaf
3
,
Kathryn E Huey-Tubman
1
,
Yu E Lee
1
,
Davide F Robbiani
4
5
,
Michel C Nussenzweig
4
6
,
Anthony P West Jr
1
,
Pamela J Bjorkman
7
Affiliations
1
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
2
Beckman Institute, California Institute of Technology, Pasadena, CA, USA.
3
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
4
Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
5
Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.
6
Howard Hughes Medical Institute, Chevy Chase, MD, USA.
7
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
[email protected]
.
PMID:
38565636
DOI:
10.1038/s41586-024-07344-w
No abstract available
Publication types
Published Erratum